Quantification of atorvastatin calcium in tablets by FT-Raman spectroscopy

Journal of Pharmaceutical and Biomedical Analysis

Volumn 49, Issue 1, 2009, Pages 168-172

  Mazurek, Sylwester ^a   Szostak, Roman ^a  

^a UNIVERSITY OF WROC AW   (Poland)

Author keywords

Active ingredient quantification; Atorvastatin calcium; Chemometrics; FT Raman spectroscopy

Indexed keywords

ATORVASTATIN;

ARTICLE; ARTIFICIAL NEURAL NETWORK; CALIBRATION; DIAGNOSTIC ACCURACY; DRUG DETERMINATION; DRUG QUALITY; PARTIAL LEAST SQUARES REGRESSION; PREDICTION; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; RAMAN SPECTROMETRY; REFERENCE VALUE; TABLET FORMULATION; ULTRAVIOLET SPECTROSCOPY; VALIDATION PROCESS;

CALIBRATION; CHEMISTRY, PHARMACEUTICAL; HEPTANOIC ACIDS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LEAST-SQUARES ANALYSIS; NEURAL NETWORKS (COMPUTER); PHARMACEUTICAL PREPARATIONS; PRINCIPAL COMPONENT ANALYSIS; PYRROLES; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; SPECTROPHOTOMETRY, ULTRAVIOLET; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; SPECTRUM ANALYSIS, RAMAN; TABLETS; TIME FACTORS;

EID: 58249143553     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2008.10.015     Document Type: Article

References (26)

1. Lea A.P., and McTavish D. Drugs 53 (1997) 828-847
2. Ertürk S., Aktaş S.S., Ersoy L., and Fiçiocioǧlu S. J. Pharm. Biomed. Anal. 33 (2003) 1017-1023
3. Nováková L., Šatínsky D., and Solich P. Trends Anal. Chem. 27 (2008) 352-367
4. Altuntas T.G., and Erk N. J. Liq. Chromatogr. Relat. Technol. 27 (2004) 83-93
5. Miao X., and Metcalfe C.D. J. Chromatogr. A 998 (2003) 133-141
6. Shah D.A., Bhatt K.K., Mehta R.S., Shankar M.B., Baldania S.L., and Ghandi T.R. Ind. J. Pharm. Sci. 69 (2007) 546-549
7. Jemal M., Ouyang Z., Chen B.C., and Teitz D. Rapid Commun. Mass Spectrom. 13 (1999) 1003-1015
8. Bullen W.W., Miller R.A., and Hayes R.N. J. Am. Soc. Mass Spectrom. 10 (1999) 55-66
9. Guihen E., Sisk G.D., Scully N.M., and Glennon J.D. Electrophoresis 27 (2006) 2338-2347
10. Erk N. Anal. Lett. 36 (2003) 2699-2711
11. Nagaraj K., Vipul M., and Rajshree. Anal. Sci. 23 (2007) 445-451
12. Sonavane S.S., Shirkhedgar A.A., Fursule R.A., and Surana S.J. Eurasian J. Anal. Chem. 1 (2006) 31-41
13. Skorda D., and Kontoyannis C.G. Talanta 47 (2008) 1066-1070
14. Strachan C.J., Rades T., Gordon K.C., and Rantanen J. J. Pharm. Pharmacol. 59 (2007) 179-192
15. Bell S.E.J. In: Šašić S. (Ed). Pharmaceutical Applications of Raman Spectroscopy (2008), J. Wiley & Sons, Hoboken 29-64
16. Skoulika S.G., and Ggeorgiou C.A. Appl. Spectrosc. 55 (2001) 1259-1265
17. Szostak R., and Mazurek S. Analyst 127 (2002) 144-148
18. Dyrby M., Engelsen S.B., Nørgaard L., Bruhn M., and Lundsberg-Nielsen L. Appl. Spectrosc. 56 (2002) 579-585
19. Mazurek S., and Szostak R. J. Pharm. Biomed. Anal. 40 (2006) 1235-1242
20. Martens H., and Næs T. Multivariate Calibration (1989), Wiley, Chichester
21. Wold S., Sjöström M., and Eriksson L. Chemom. Intell. Lab. Syst. 58 (2001) 109-130
22. Despagne F., and Massart D.L. Analyst 123 (1998) 157R-178R
23. Zupan J., Novič M., and Ruisánchez I. Chemom. Intell. Lab. Syst. 38 (1997) 1-23
24. Zupan J., and Gasteiger J. Neural Networks in Chemistry and Drug Design (1999), Wiley-VCH, Weinheim
25. J. Zupan, K-CTR program for Kohonen and counter-propagation neural networking, KI DN-1452.
26. Otto M., and Wegscheider W. Anal. Chem. 57 (1985) 63-69